Symbols / LMAT Stock $109.75 +2.32% LeMaitre Vascular, Inc.

Healthcare • Medical Instruments & Supplies • United States • NGM
LMAT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. George W. LeMaitre
Exch · Country NGM · United States
Market Cap 2.51B
Enterprise Value 2.27B
Income 57.73M
Sales 249.60M
FCF (ttm) 47.35M
Book/sh 17.28
Cash/sh 15.77
Employees 646
Insider 10d —
IPO Oct 19, 2006
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 31.75%
P/E 43.55
Forward P/E 34.46
PEG 3.25
P/S 10.05
P/B 6.35
P/C —
EV/EBITDA 30.87
EV/Sales 9.09
Quick Ratio 10.81
Current Ratio 12.89
Debt/Eq 47.16
LT Debt/Eq —
EPS (ttm) 2.52
EPS next Y 3.18
EPS Growth 41.40%
Revenue Growth 15.70%
EPS Gr Q/Q 39.30%
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-25
ROA 6.76%
ROE 15.80%
ROIC —
Gross Margin 70.45%
Oper. Margin 21.77%
Profit Margin 23.13%
Shs Outstand 22.85M
Shs Float 21.15M
Insider Own 6.90%
Instit Own 97.14%
Short Float 7.55%
Short Ratio 5.41
Short Interest 1.37M
52W High 118.01
vs 52W High -7.00%
52W Low 78.01
vs 52W Low 40.69%
Beta 0.67
Impl. Vol. 55.30%
Rel Volume 0.74
Avg Volume 222.88K
Volume 164.40K
Target (mean) $111.22
Tgt Median $113.00
Tgt Low $94.00
Tgt High $124.00
# Analysts 9
Recom None
Prev Close $107.27
Price $109.75
Change 2.32%
About

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$111.22
Mean price target
2. Current target
$109.75
Latest analyst target
3. DCF / Fair value
$37.30
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$109.75
Low
$94.00
High
$124.00
Mean
$111.22

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-26 main Barrington Research Outperform → Outperform $105
2026-02-26 reit Roth Capital Buy → Buy $117
2026-02-26 main Wells Fargo Equal-Weight → Equal-Weight $94
2026-02-26 main Citizens Market Outperform → Market Outperform $118
2026-02-20 main Barrington Research Outperform → Outperform $95
2025-11-07 main Wells Fargo Equal-Weight → Equal-Weight $93
2025-10-15 main Barrington Research Outperform → Outperform $95
2025-09-23 main Barrington Research Outperform → Outperform $95
2025-08-06 main Cantor Fitzgerald Neutral → Neutral $95
2025-08-06 up Barrington Research Market Perform → Outperform $95
2025-07-22 reit Barrington Research Market Perform → Market Perform —
2025-02-28 main Lake Street Buy → Buy $110
2025-02-28 main Citizens Capital Markets Buy → Buy $110
2025-02-28 down Barrington Research Outperform → Market Perform —
2025-02-13 init Wells Fargo — → Equal-Weight $95
2024-11-01 reit Oppenheimer Outperform → Outperform $93
2024-11-01 main Barrington Research Outperform → Outperform $93
2024-10-15 init Cantor Fitzgerald — → Neutral $96
2024-09-20 main Barrington Research Outperform → Outperform $92
2024-08-20 main JMP Securities Market Outperform → Market Outperform $100
News
RSS: Latest LMAT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-22 PELLEGRINO JOSEPH P JR Director — 2,941 $35.48 $104,347
2026-03-11 KAMKE TRENT G Officer — 2,625 $108.50 $284,812
2026-03-11 KAMKE TRENT G Officer — 2,625 $35.48 $93,135
2026-03-11 ROBERTS DAVID BRIAN President — 3,311 $107.68 $356,586
2026-03-10 LEBLANC DORIAN PAUL CPA Chief Financial Officer — 2 — —
2026-03-02 LEMAITRE GEORGE W Chief Executive Officer — 5,000 $0.00 $0
2026-03-02 LEMAITRE GEORGE W Chief Executive Officer — 205,930 $106.76 $22,043,375
2026-02-27 KAMKE TRENT G Officer — 1,044 $110.29 $115,143
2026-02-27 ROBERTS DAVID BRIAN President — 8,464 $106.80 $903,958
2026-02-26 KAMKE TRENT G Officer — 1,051 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
249.60
+13.53%
219.86
+13.63%
193.48
+19.69%
161.65
Operating Revenue
249.60
+13.53%
219.86
+13.63%
193.48
+19.69%
161.65
Cost Of Revenue
71.06
+3.05%
68.96
+3.80%
66.44
+17.06%
56.76
Reconciled Cost Of Revenue
71.06
+3.05%
68.96
+3.80%
66.44
+17.06%
56.76
Gross Profit
178.54
+18.32%
150.90
+18.77%
127.05
+21.12%
104.90
Operating Expense
110.63
+12.15%
98.64
+9.79%
89.85
+19.87%
74.96
Research And Development
14.14
-9.65%
15.65
-7.76%
16.97
+27.62%
13.29
Selling General And Administration
96.49
+16.26%
83.00
+13.87%
72.89
+18.19%
61.67
Selling And Marketing Expense
54.46
+16.53%
46.74
+13.84%
41.05
+24.70%
32.92
General And Administrative Expense
42.02
+15.90%
36.26
+13.90%
31.83
+10.74%
28.75
Other Gand A
42.02
+15.90%
36.26
+13.90%
31.83
+10.74%
28.75
Total Expenses
181.69
+8.40%
167.61
+7.24%
156.29
+18.66%
131.72
Operating Income
67.91
+29.96%
52.26
+40.48%
37.20
+24.26%
29.94
Total Operating Income As Reported
67.91
+29.96%
52.26
+42.34%
36.71
+36.84%
26.83
EBITDA
90.79
+36.14%
66.69
+36.13%
48.99
+32.68%
36.92
Normalized EBITDA
77.69
+25.84%
61.74
+33.06%
46.40
+15.91%
40.03
Reconciled Depreciation
10.42
+8.43%
9.61
+0.98%
9.52
+0.87%
9.43
EBIT
80.37
+40.80%
57.08
+44.60%
39.48
+43.60%
27.49
Total Unusual Items
13.09
+164.58%
4.95
+90.93%
2.59
+183.42%
-3.11
Total Unusual Items Excluding Goodwill
13.09
+164.58%
4.95
+90.93%
2.59
+183.42%
-3.11
Special Income Charges
0.00
0.00
+100.00%
-0.48
+84.39%
-3.11
Restructuring And Mergern Acquisition
0.00
0.00
-100.00%
0.48
-84.39%
3.11
Net Income
57.73
+31.10%
44.04
+46.28%
30.11
+45.89%
20.64
Pretax Income
75.18
+32.19%
56.88
+44.08%
39.48
+43.60%
27.49
Net Non Operating Interest Income Expense
-5.18
-2428.78%
-0.20
0.00
-100.00%
0.99
Interest Expense Non Operating
5.18
+2428.78%
0.20
0.00
0.00
Net Interest Income
-5.18
-2428.78%
-0.20
0.00
-100.00%
0.99
Interest Expense
5.18
+2428.78%
0.20
0.00
0.00
Interest Income Non Operating
—
4.95
+60.84%
3.08
+212.07%
0.99
Interest Income
—
4.95
+60.84%
3.08
+212.07%
0.99
Other Income Expense
12.46
+158.21%
4.82
+111.76%
2.28
+166.38%
-3.43
Other Non Operating Income Expenses
-0.64
-410.40%
-0.12
+60.19%
-0.31
+3.38%
-0.33
Gain On Sale Of Security
13.09
+164.58%
4.95
+60.84%
3.08
—
Tax Provision
17.45
+35.94%
12.84
+37.00%
9.37
+36.71%
6.85
Tax Rate For Calcs
0.00
+2.65%
0.00
-4.64%
0.00
-4.82%
0.00
Tax Effect Of Unusual Items
3.04
+171.60%
1.12
+82.07%
0.61
+179.40%
-0.77
Net Income Including Noncontrolling Interests
57.73
+31.10%
44.04
+46.28%
30.11
+45.89%
20.64
Net Income From Continuing Operation Net Minority Interest
57.73
+31.10%
44.04
+46.28%
30.11
+45.89%
20.64
Net Income From Continuing And Discontinued Operation
57.73
+31.10%
44.04
+46.28%
30.11
+45.89%
20.64
Net Income Continuous Operations
57.73
+31.10%
44.04
+46.28%
30.11
+45.89%
20.64
Normalized Income
47.68
+18.58%
40.21
+42.95%
28.13
+22.46%
22.97
Net Income Common Stockholders
57.73
+31.10%
44.04
+46.28%
30.11
+45.89%
20.64
Diluted EPS
2.52
+30.57%
1.93
+44.03%
1.34
+44.09%
0.93
Basic EPS
2.55
+30.10%
1.96
+44.12%
1.36
+44.68%
0.94
Basic Average Shares
22.64
+0.83%
22.45
+1.06%
22.22
+1.10%
21.98
Diluted Average Shares
22.93
+0.66%
22.78
+1.59%
22.42
+1.14%
22.17
Diluted NI Availto Com Stockholders
57.73
+31.10%
44.04
+46.28%
30.11
+45.89%
20.64
Gain On Sale Of PPE
—
—
—
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
615.69
+11.58%
551.82
+59.13%
346.78
+11.69%
310.48
Current Assets
468.23
+16.42%
402.19
+106.68%
194.60
+20.32%
161.73
Cash Cash Equivalents And Short Term Investments
359.12
+19.82%
299.72
+185.25%
105.07
+27.07%
82.69
Cash And Cash Equivalents
28.24
+10.29%
25.61
+5.53%
24.27
+26.84%
19.13
Other Short Term Investments
330.88
+20.71%
274.11
+239.23%
80.81
+27.14%
63.56
Receivables
33.61
+11.80%
30.06
+19.94%
25.06
+13.72%
22.04
Accounts Receivable
33.61
+11.80%
30.06
+19.94%
25.06
+13.72%
22.04
Gross Accounts Receivable
35.01
+11.38%
31.43
+20.87%
26.00
+13.68%
22.88
Allowance For Doubtful Accounts Receivable
-1.40
-2.26%
-1.37
-45.48%
-0.94
-12.69%
-0.83
Inventory
58.25
+4.12%
55.94
+6.90%
52.33
+15.58%
45.28
Raw Materials
20.89
+9.33%
19.11
+4.23%
18.33
+22.80%
14.93
Work In Process
2.92
+35.47%
2.16
-24.82%
2.87
-21.65%
3.66
Finished Goods
34.43
-0.70%
34.68
+11.39%
31.13
+16.65%
26.69
Prepaid Assets
—
—
—
—
Current Deferred Assets
12.18
+35.51%
8.98
+56.34%
5.75
+15.12%
4.99
Other Current Assets
5.08
-32.09%
7.48
+17.24%
6.38
-5.21%
6.73
Total Non Current Assets
147.46
-1.45%
149.62
-1.68%
152.18
+2.31%
148.74
Net PPE
42.76
+2.87%
41.57
+4.49%
39.78
+18.63%
33.53
Gross PPE
71.16
+8.17%
65.78
+7.37%
61.27
+4.45%
58.66
Accumulated Depreciation
-28.40
-17.27%
-24.22
-12.70%
-21.49
+14.47%
-25.12
Properties
26.15
+3.56%
25.25
+20.36%
20.98
+37.74%
15.23
Machinery Furniture Equipment
29.24
+23.05%
23.76
+6.75%
22.26
-19.90%
27.79
Other Properties
15.76
-6.00%
16.77
-6.98%
18.03
+15.31%
15.63
Goodwill And Other Intangible Assets
99.03
-2.68%
101.76
-5.47%
107.66
-4.28%
112.47
Goodwill
65.94
+0.00%
65.94
+0.00%
65.94
+0.00%
65.94
Other Intangible Assets
33.09
-7.62%
35.82
-14.13%
41.71
-10.35%
46.53
Non Current Deferred Assets
0.76
-46.74%
1.43
+42.07%
1.00
-42.52%
1.75
Non Current Deferred Taxes Assets
0.76
-46.74%
1.43
+42.07%
1.00
-42.52%
1.75
Other Non Current Assets
4.91
+0.78%
4.87
+30.16%
3.74
+277.40%
0.99
Total Liabilities Net Minority Interest
222.17
+3.56%
214.53
+338.90%
48.88
+15.62%
42.27
Current Liabilities
36.32
+18.68%
30.61
+2.44%
29.88
+17.96%
25.33
Payables And Accrued Expenses
33.06
+24.78%
26.49
-3.25%
27.38
+19.74%
22.87
Payables
23.59
+34.69%
17.52
+0.23%
17.48
+23.76%
14.12
Accounts Payable
3.65
+107.04%
1.76
-52.84%
3.73
+28.63%
2.90
Current Accrued Expenses
9.46
+5.44%
8.98
-9.40%
9.91
+13.25%
8.75
Pensionand Other Post Retirement Benefit Plans Current
—
—
—
10.77
Total Tax Payable
19.95
+26.60%
15.76
+14.65%
13.74
+22.50%
11.22
Income Tax Payable
1.66
+159.94%
0.64
+63.85%
0.39
-13.14%
0.45
Current Debt And Capital Lease Obligation
2.94
+9.81%
2.68
+8.50%
2.47
+31.02%
1.89
Current Capital Lease Obligation
2.94
+9.81%
2.68
+8.50%
2.47
+31.02%
1.89
Other Current Liabilities
0.32
-77.53%
1.43
+5870.83%
0.02
-95.81%
0.57
Total Non Current Liabilities Net Minority Interest
185.85
+1.05%
183.92
+868.05%
19.00
+12.11%
16.95
Long Term Debt And Capital Lease Obligation
182.65
-0.19%
183.00
+1000.84%
16.62
+13.01%
14.71
Long Term Debt
168.65
+0.52%
167.77
—
—
Long Term Capital Lease Obligation
14.00
-8.07%
15.23
-8.37%
16.62
+13.01%
14.71
Tradeand Other Payables Non Current
0.50
-11.89%
0.57
-10.20%
0.64
+0.16%
0.64
Non Current Deferred Liabilities
1.74
+1941.18%
0.09
-20.56%
0.11
+55.07%
0.07
Non Current Deferred Taxes Liabilities
1.74
+1941.18%
0.09
-20.56%
0.11
+55.07%
0.07
Other Non Current Liabilities
0.96
+272.20%
0.26
-84.12%
1.63
+6.53%
1.53
Stockholders Equity
393.52
+16.67%
337.29
+13.22%
297.90
+11.07%
268.20
Common Stock Equity
393.52
+16.67%
337.29
+13.22%
297.90
+11.07%
268.20
Capital Stock
0.24
+0.83%
0.24
+1.26%
0.24
+0.84%
0.24
Common Stock
0.24
+0.83%
0.24
+1.26%
0.24
+0.84%
0.24
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
24.40
+1.01%
24.15
+1.01%
23.91
+1.08%
23.66
Ordinary Shares Number
22.77
+0.99%
22.55
+0.99%
22.33
+1.09%
22.09
Treasury Shares Number
1.62
+1.28%
1.60
+1.22%
1.58
+1.01%
1.57
Additional Paid In Capital
228.41
+6.85%
213.76
+6.48%
200.75
+6.07%
189.27
Retained Earnings
184.72
+27.31%
145.09
+25.70%
115.43
+18.06%
97.77
Gains Losses Not Affecting Retained Earnings
-2.41
+61.01%
-6.18
-33.71%
-4.62
+23.31%
-6.03
Treasury Stock
17.44
+11.66%
15.62
+12.37%
13.90
+6.54%
13.05
Other Equity Adjustments
-2.41
+61.01%
-6.18
-33.71%
-4.62
+23.31%
-6.03
Total Equity Gross Minority Interest
393.52
+16.67%
337.29
+13.22%
297.90
+11.07%
268.20
Total Capitalization
562.16
+11.31%
505.06
+69.54%
297.90
+11.07%
268.20
Working Capital
431.91
+16.23%
371.58
+125.59%
164.72
+20.76%
136.40
Invested Capital
562.16
+11.31%
505.06
+69.54%
297.90
+11.07%
268.20
Total Debt
185.59
-0.05%
185.69
+872.43%
19.09
+15.06%
16.60
Net Debt
140.40
-1.24%
142.16
—
—
Capital Lease Obligations
16.95
-5.39%
17.91
-6.19%
19.09
+15.06%
16.60
Net Tangible Assets
294.48
+25.03%
235.53
+23.80%
190.24
+22.16%
155.73
Tangible Book Value
294.48
+25.03%
235.53
+23.80%
190.24
+22.16%
155.73
Interest Payable
1.80
+1147.92%
0.14
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
81.25
+84.14%
44.12
+20.06%
36.75
+44.81%
25.38
Cash Flow From Continuing Operating Activities
81.25
+84.14%
44.12
+20.06%
36.75
+44.81%
25.38
Net Income From Continuing Operations
57.73
+31.10%
44.04
+46.28%
30.11
+45.89%
20.64
Depreciation Amortization Depletion
10.42
+8.43%
9.61
+0.98%
9.52
+0.87%
9.43
Depreciation And Amortization
10.42
+8.43%
9.61
+0.98%
9.52
+0.87%
9.43
Other Non Cash Items
0.87
+345.41%
0.20
+351.28%
-0.08
+27.78%
-0.11
Stock Based Compensation
7.83
+19.15%
6.57
+23.48%
5.32
+27.46%
4.17
Provisionand Write Offof Assets
0.82
+0.49%
0.81
+136.34%
0.34
-46.00%
0.64
Asset Impairment Charge
2.66
-13.94%
3.09
+38.22%
2.24
-13.02%
2.57
Deferred Tax
2.31
+612.64%
-0.45
-157.60%
0.78
+530.22%
-0.18
Deferred Income Tax
2.31
+612.64%
-0.45
-157.60%
0.78
+530.22%
-0.18
Operating Gains Losses
-0.18
-148.62%
0.36
+264.55%
-0.22
-113.59%
1.62
Unrealized Gain Loss On Investment Securities
0.54
0.00
0.00
—
Net Foreign Currency Exchange Gain Loss
-0.18
-148.62%
0.36
+151.35%
-0.70
-123.81%
-0.32
Gain Loss On Sale Of PPE
—
0.00
0.00
+100.00%
-0.02
Change In Working Capital
-1.75
+91.30%
-20.10
-78.62%
-11.25
+16.03%
-13.40
Change In Receivables
-2.95
+54.08%
-6.42
-104.72%
-3.13
+11.27%
-3.53
Changes In Account Receivables
-2.95
+54.08%
-6.42
-104.72%
-3.13
+11.27%
-3.53
Change In Inventory
-7.22
+31.69%
-10.57
-7.96%
-9.79
-32.03%
-7.42
Change In Prepaid Assets
2.43
+204.08%
-2.33
+20.28%
-2.92
+5.56%
-3.10
Change In Payables And Accrued Expense
6.00
+869.58%
-0.78
-116.94%
4.60
+613.02%
0.65
Change In Accrued Expense
1.80
+1147.92%
0.14
0.00
—
Change In Payable
4.20
+554.82%
-0.92
-120.07%
4.60
+613.02%
0.65
Change In Account Payable
4.20
+554.82%
-0.92
-120.07%
4.60
+613.02%
0.65
Investing Cash Flow
-64.94
+67.55%
-200.12
-709.71%
-24.71
-138.31%
-10.37
Cash Flow From Continuing Investing Activities
-64.94
+67.55%
-200.12
-709.71%
-24.71
-138.31%
-10.37
Net PPE Purchase And Sale
-6.78
+2.57%
-6.96
+4.17%
-7.26
-206.41%
-2.37
Purchase Of PPE
-6.78
+2.57%
-6.96
+4.17%
-7.26
-124.99%
-3.23
Sale Of PPE
—
0.00
0.00
-100.00%
0.86
Capital Expenditure
-6.78
+2.57%
-6.96
+4.17%
-7.26
-124.99%
-3.23
Net Investment Purchase And Sale
-56.26
+70.87%
-193.16
-1067.05%
-16.55
-106.89%
-8.00
Purchase Of Investment
-641.33
-130.75%
-277.94
-1579.28%
-16.55
-106.89%
-8.00
Sale Of Investment
585.07
+590.10%
84.78
0.00
0.00
Net Business Purchase And Sale
-1.90
0.00
+100.00%
-0.90
0.00
Purchase Of Business
-1.90
0.00
+100.00%
-0.90
0.00
Gain Loss On Sale Of Business
0.00
0.00
-100.00%
0.48
-75.18%
1.95
Financing Cash Flow
-14.54
-109.20%
158.10
+2317.11%
-7.13
+22.77%
-9.23
Cash Flow From Continuing Financing Activities
-14.54
-109.20%
158.10
+2317.11%
-7.13
+22.77%
-9.23
Net Issuance Payments Of Debt
0.00
-100.00%
169.27
0.00
0.00
Issuance Of Debt
0.00
-100.00%
169.27
0.00
0.00
Repayment Of Debt
—
—
0.00
0.00
Long Term Debt Issuance
0.00
-100.00%
169.27
0.00
0.00
Long Term Debt Payments
—
—
0.00
0.00
Net Long Term Debt Issuance
0.00
-100.00%
169.27
0.00
0.00
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
—
6.44
+4.38%
6.17
+78.02%
3.47
Common Stock Payments
—
—
—
-0.64
Common Stock Dividend Paid
-18.11
-25.95%
-14.38
-15.50%
-12.45
-13.29%
-10.99
Cash Dividends Paid
-18.11
-25.95%
-14.38
-15.50%
-12.45
-13.29%
-10.99
Repurchase Of Capital Stock
—
—
—
-0.64
Proceeds From Stock Option Exercised
5.00
+5.95%
4.72
-11.21%
5.32
+928.19%
-0.64
Net Other Financing Charges
-1.43
+4.91%
-1.51
—
-1.07
Changes In Cash
1.77
-15.95%
2.11
-57.06%
4.91
-15.04%
5.77
Effect Of Exchange Rate Changes
0.86
+212.94%
-0.77
-432.61%
0.23
+146.56%
-0.49
Beginning Cash Position
25.61
+5.53%
24.27
+26.84%
19.13
+38.10%
13.86
End Cash Position
28.24
+10.29%
25.61
+5.53%
24.27
+26.84%
19.13
Free Cash Flow
74.47
+100.39%
37.16
+26.03%
29.49
+33.13%
22.15
Income Tax Paid Supplemental Data
13.44
+4.69%
12.84
+70.05%
7.55
-9.52%
8.34
Change In Interest Payable
1.80
+1147.92%
0.14
0.00
—
Common Stock Issuance
—
6.44
+4.38%
6.17
+78.02%
3.47
Issuance Of Capital Stock
—
6.44
+4.38%
6.17
+78.02%
3.47
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category